241 related articles for article (PubMed ID: 19268360)
1. Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein.
Barsoum AL; Liu B; Rohrer JW; Coggin JH; Tucker JA; Pannell LK; Schwarzenberger PO
Biomaterials; 2009 Jun; 30(17):3091-9. PubMed ID: 19268360
[TBL] [Abstract][Full Text] [Related]
2. 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers.
Coggin JH; Barsoum AL; Rohrer JW
Anticancer Res; 1999; 19(6C):5535-42. PubMed ID: 10697612
[TBL] [Abstract][Full Text] [Related]
3. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Siegel S; Wagner A; Kabelitz D; Marget M; Coggin J; Barsoum A; Rohrer J; Schmitz N; Zeis M
Blood; 2003 Dec; 102(13):4416-23. PubMed ID: 12869512
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a soluble partially purified oncofetal antigen from murine fibrosarcoma in syngeneic mice.
Barsoum AL; Coggin JH
J Biol Response Mod; 1989 Dec; 8(6):579-92. PubMed ID: 2600602
[TBL] [Abstract][Full Text] [Related]
5. Identification of oncofetal antigen/immature laminin receptor protein epitopes that activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell clones.
Rohrer JW; Barsoum AL; Coggin JH
J Immunol; 2006 Mar; 176(5):2844-56. PubMed ID: 16493041
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine models.
McClintock SD; Warner RL; Ali S; Chekuri A; Dame MK; Attili D; Knibbs RK; Aslam MN; Sinkule J; Morgan AC; Barsoum A; Smith LB; Beer DG; Johnson KJ; Varani J
Cancer Biol Ther; 2015; 16(5):724-32. PubMed ID: 25799942
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, and refolding of a secretory protein ESAT-6 of Mycobacterium tuberculosis.
Wang BL; Xu Y; Wu CQ; Xu YM; Wang HH
Protein Expr Purif; 2005 Feb; 39(2):184-8. PubMed ID: 15642469
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunity.
Biragyn A; Schiavo R; Olkhanud P; Sumitomo K; King A; McCain M; Indig FE; Almanzar G; Baatar D
J Immunol; 2007 Jul; 179(2):1381-8. PubMed ID: 17617631
[TBL] [Abstract][Full Text] [Related]
10. High-level expression, purification, and renaturation of recombinant murine interleukin-2 from Escherichia coli.
Guisez Y; Demolder J; Mertens N; Raeymaekers A; Plaetinck G; Robbens J; Vandekerckhove J; Remaut E; Fiers W
Protein Expr Purif; 1993 Jun; 4(3):240-6. PubMed ID: 8390881
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of the cancer antigen SSX2: a potential cancer vaccine.
Huang CJ; Chen RH; Vannelli T; Lee F; Ritter E; Ritter G; Old LJ; Batt CA
Protein Expr Purif; 2007 Dec; 56(2):212-9. PubMed ID: 17931884
[TBL] [Abstract][Full Text] [Related]
12. Expression of biologically active human SPARC in Escherichia coli.
Bassuk JA; Baneyx F; Vernon RB; Funk SE; Sage EH
Arch Biochem Biophys; 1996 Jan; 325(1):8-19. PubMed ID: 8554346
[TBL] [Abstract][Full Text] [Related]
13. Generation of monoclonal antibodies for the assessment of protein purification by recombinant ribosomal coupling.
Kristensen J; Sperling-Petersen HU; Mortensen KK; Sørensen HP
Int J Biol Macromol; 2005 Dec; 37(4):212-7. PubMed ID: 16330094
[TBL] [Abstract][Full Text] [Related]
14. Generation of cancer vaccine immunogens derived from Oncofetal antigen (OFA/iLRP) using variable epitope libraries tested in an aggressive breast cancer model.
Martínez-Cortés F; Servín-Blanco R; Domínguez-Romero AN; Munguía ME; Guzman Valle J; Odales J; Gevorkian G; Manoutcharian K
Mol Immunol; 2021 Nov; 139():65-75. PubMed ID: 34454186
[TBL] [Abstract][Full Text] [Related]
15. Oncofetal antigen/immature laminin receptor protein in pregnancy and cancer.
Barsoum AL; Schwarzenberger PO
Cell Mol Biol Lett; 2014 Sep; 19(3):393-406. PubMed ID: 25082063
[TBL] [Abstract][Full Text] [Related]
16. Purification and antigenicity of two recombinant forms of Boophilus microplus yolk pro-cathepsin expressed in inclusion bodies.
Leal AT; Pohl PC; Ferreira CA; Nascimento-Silva MC; Sorgine MH; Logullo C; Oliveira PL; Farias SE; da Silva Vaz I; Masuda A
Protein Expr Purif; 2006 Jan; 45(1):107-14. PubMed ID: 16122942
[TBL] [Abstract][Full Text] [Related]
17. Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy.
Tan Y; Xu M; Tan X; Tan X; Wang X; Saikawa Y; Nagahama T; Sun X; Lenz M; Hoffman RM
Protein Expr Purif; 1997 Mar; 9(2):233-45. PubMed ID: 9056489
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy.
Gjerstorff MF; Besir H; Larsen MR; Ditzel HJ
Protein Expr Purif; 2010 Oct; 73(2):217-22. PubMed ID: 20546897
[TBL] [Abstract][Full Text] [Related]
19. [Cloning and expression of the gene of chymotrypsin-like protease of human kallikrein-7 in Escherichia coli and isolation of recombinant protein].
Zakabunin AI; Mishukova OV; Khrapov EA; Sergeichev DS; Boiarskikh UA; Sverdlov ED; Filipenko ML
Mol Gen Mikrobiol Virusol; 2007; (2):21-5. PubMed ID: 17598454
[TBL] [Abstract][Full Text] [Related]
20. Identification of partial complementary DNA clones encoding a 59-kd protein with characteristics of a unique oncofetal antigen.
Rashid HU; Barsoum AL; Cao TM; Coggin JH
J Natl Cancer Inst; 1994 Apr; 86(7):515-26. PubMed ID: 8133535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
